51 results about "Nasal region" patented technology

An interface for positive pressure respiratory therapy includes a mask assembly having a mask seal and a mask shell. The mask assembly is positioned lower than and exposes a bridge of the user's nose. The mask seal includes first and second portions on respective first and second sides of a nasal region that contact opposing sides of the user's nose. The first and second portions each include supports that help maintain a shape of the mask seal. A pair of covers can be supported relative to the mask assembly and adjacent a respective one of the first and second portions of the mask seal. The covers limit expansion of the first and second portions of the mask seal in response to pressurized air within the mask seal. The supports of the first and second portions can transfer load from the mask seal to the covers.

The invention relates to a system and / or an apparatus for an improved helmet system that may help reduce the severity of injuries by enhancing overall helmet protection through uniquely designed facemasks and facemask bumpers. The facemask and facemask bumpers that are particularly adapted to redistribute pressure and impact forces, decrease vibration, sudden shock, noise and / or the peak forces transmitted from the facemask to the rest of the helmet system. The facemask bumpers may be disposed into specific regions of the facemask, including the brow region, the glabella region, orbit region, the frontal region, the mandible (front, right and / or left side) region, the maxilla region, the nasal region, zygomatic region, the ethmoid region, the lacrimal region, the sphenoid region and / or any combination thereof.

The invention provides a nomeline nasal-brain delivery preparation for transnasal region mucosa administration, and an auxiliary material mixture of the nasal-brain delivery preparation comprises 1) phospholipid, and 2) any one of diluent ethyl oleate, isopropyl myristate, sesame oil or castor oil; optionally, the auxiliary material mixture can also comprise 3) a dissolving agent such as ethanol or diethylene glycol monoethyl ether, the auxiliary material mixture is a non-aqueous system, and a solution prepared from the mixture of the two or three auxiliary materials can be absorbed by the nasal meatus olfactory mucosa after being administrated through the nasal region mucosa, can be quickly conducted to the brain olfactory bulb region along olfactory nerves and cerebrospinal fluid, and can be used for treating the brain olfactory bulb. The problems that the peripheral side effect is high due to poor brain targeting of the medicine, the medicine takes effect slowly and the like are solved.

An interface for use in providing positive pressure respiratory therapy, the interface comprising:a mask assembly comprising a mask seal and a mask shell, the mask assembly configured to be fully positioned lower than a bridge of a nose of a face of a user and to provide an exposed bridge of the nose of the user, the mask seal being connected to the mask shell, a nasal region comprising at least one nasal opening, the mask seal comprising a first paddle on a first side of the nasal region and a second paddle on a second side of the nasal region, the first paddle configured to contact one side of the nose of the user and the second paddle configured to contact the other side of the nose of the user;

The invention relates to a system and / or an apparatus for an improved helmet system that may help reduce the severity of injuries by enhancing overall helmet protection through uniquely designed facemasks and facemask bumpers. The facemask and facemask bumpers that are particularly adapted to redistribute pressure and impact forces, decrease vibration, sudden shock, noise and / or the peak forces transmitted from the facemask to the rest of the helmet system. The facemask bumpers may be disposed into specific regions of the facemask, including the brow region, the glabella region, orbit region, the frontal region, the mandible (front, right and / or left side) region, the maxilla region, the nasal region, zygomatic region, the ethmoid region, the lacrimal region, the sphenoid region and / or any combination thereof.

The diving full face mask specifically comprises a frame body and a breathing tube arranged at the top of the frame body, a first soft mask body used for covering the face and a second soft mask body used for covering the mouth and nose area are arranged in the frame body, and a connecting cavity is formed in the first soft mask body; the connecting cavity comprises a long cavity body and a short cavity body; one end of the long cavity is communicated with the breathing tube, and the other end of the long cavity is communicated with the second soft cover; one end of the short cavity is communicated with the breathing tube, and the other end of the short cavity is communicated with the first soft cover. The diving full face mask effectively solves the problem that in the breathing process of an existing diving full face mask, the concentration of carbon dioxide is increased, and the carbon dioxide cannot be effectively and rapidly discharged, and safety and use experience are improved. Meanwhile, the diving full face mask has good sealing performance and universality, is not prone to water seepage and can be suitable for more face types.

Disclosed herein are protective apparatuses, and associated systems, for minimizing the risk of transmission of SARS-CoV-2 and / or other infectious diseases between individuals in close proximity to one another including, for example, transmission through droplets projecting from the mouth or nasal region of an infected individual. Said apparatuses may comprise a substantially transparent shield component and a handle component comprising a connecting aspect. The protective apparatuses may comprise light emitting diodes and associated control means. The protective apparatuses of the present disclosure may further comprise a camera communicatively connected to a display screen.

An interface for positive pressure respiratory therapy includes a mask assembly having a mask seal and a mask shell. The mask assembly is positioned lower than and exposes a bridge of the user's nose. The mask seal includes first and second portions on respective first and second sides of a nasal region that contact opposing sides of the user's nose. The first and second portions each include supports that help maintain a shape of the mask seal. A pair of covers can be supported relative to the mask assembly and adjacent a respective one of the first and second portions of the mask seal. The covers limit expansion of the first and second portions of the mask seal in response to pressurized air within the mask seal. The supports of the first and second portions can transfer load from the mask seal to the covers.

Embodiments provide targeted delivery of powder medications (high and low dose) within the nose and to different nasal regions. Oscillating jet technology provides a unique approach to minimize hotspot formation and the associated irritation associated with high powder mass applications together with improved posterior surface area coverage and improved drug absorption for locally acting or systemically and neurologically targeted medications.

Disclosed herein are protective apparatuses, and associated systems, for minimizing the risk of transmission of SARS-CoV-2 and / or other infectious diseases between individuals in close proximity to one another including, for example, transmission through droplets projecting from the mouth or nasal region of an infected individual. Said apparatuses may comprise a substantially transparent shield component and a handle component comprising a connecting aspect. The protective apparatuses may comprise light emitting diodes and associated control means. The protective apparatuses of the present disclosure may further comprise a camera communicatively connected to a display screen.

The invention generally relates to systems and methods for targeting of specific tissue(s) of interest in a sino-nasal region of a patient for the treatment of a rhinosinusitis condition. A device of the present invention includes an end effector comprised of one or more segments, each segment comprising one or more struts which can be in the form of loop-shaped struts or independent struts and each comprising a flexible printed circuit board (PCB) member for delivering energy to one or more target sites within the sino-nasal cavity of the patient while minimizing or avoiding collateral damage to surrounding or adjacent non-targeted tissue, such as blood vessels, bone, and non-targeted neural tissue.

A mask adapted for delivering pressurised air to a user, the mask comprising: an endoskeleton of a first resilient material encapsulated to a lamina of a second resilient material forming a mask body with a cavity. The second resilient material is more flexible than the first resilient material. The lamina having a face contactable skirt portion extending away from the endoskeleton perimeter. The skirt portion comprises an outer layer and an inner layer for providing variable contoured thickness to outer lamina segments of the face contactable portion. The face contactable skirt portion having a flexible cavity edge defining a cavity opening for receiving a nasal region. The endoskeleton and lamina has an aperture adapted to connect to an air delivery tube; the thinner flexible cavity edge is adapted to wrap into the cavity, when wrapped, the contoured thicker lamina segments wraps and seals around the sides of the nose.

Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.

The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The method includes providing a treatment device comprising a treatment comprising a plurality of electrodes and advancing the treatment element into the nasal cavity of a subject such that two or more of the plurality of electrodes of the treatment element are positioned relative to targeted neural tissue within the nasal cavity. The method further includes controlling, via a console unit operably coupled to the treatment device, delivery of one or more treatment applications applied via the treatment element for altering transmission of signals through the targeted tissue.

To provide under-nose interface assemblies improved in comfort and / or sealing performance.SOLUTION: An interface for positive pressure respiratory therapy includes a mask assembly having a mask seal and a mask shell. The mask assembly is positioned lower than and exposes a bridge of a user's nose. The mask seal includes first and second portions on respective first and second sides of a nasal region that contact opposing sides of the user's nose. The first and second portions each include supports that help maintain a shape of the mask seal. A pair of covers can each be supported relatively to the mask assembly and adjacently to a corresponding one of the first and second portions of the mask seal. The covers limit expansion of the first and second portions of the mask seal in response to pressurized air within the mask seal. The supports of the first and second portions can transfer a load from the mask seal to the covers.SELECTED DRAWING: Figure 1

Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.

The present application relates to the field of medical detection, especially to a kind of medical examination auxiliary device.The medical examination auxiliary device of the present application is connected with two connecting heads respectively fixed with two inner clamping blocks on head pad through fixing belt and elastic belt, hollow passage is arranged in right fixed seat and left fixed seat between the two connecting heads, to avoid interfering with the flow of respiratory airflow, the slight outward expansion extrusion force of inner clamping block is applied to the inner side of children's ala nasi by elastic belt, the airflow detection sensor on the inner clamping block can be easily fixed in the nostril of children, at the same time, the nostril of children is kept in the state of expansion, to ensure that the respiratory airflow in the nasal passage of children flows normally.Improve the technical problem that the existing medical detection device for sleep breathing disorder of children exists when detecting the sleep breathing of children in nasal region, the accuracy of detection is affected due to the interference of children's respiratory patency.

A mask assembly can include a mask seal. In some configurations, the mask assembly can be configured to be fully positioned lower than a bridge of a nose of a face of a user and to provide an exposed bridge of the nose of the user. The mask seal can comprise a nasal region comprising at least one nasal opening, a first paddle on a first side of the nasal region and a second paddle on a second side of the nasal region. The first paddle is configured to contact one side of the nose of the user and the second paddle is configured to contact the other side of the nose of the user.

Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.

The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The method includes providing a treatment device comprising a treatment comprising a plurality of electrodes and advancing the treatment element into the nasal cavity of a subject such that two or more of the plurality of electrodes of the treatment element are positioned relative to targeted neural tissue within the nasal cavity. The method further includes controlling, via a console unit operably coupled to the treatment device, delivery of one or more treatment applications applied via the treatment element for altering transmission of signals through the targeted tissue.

A mask assembly can include a mask seal. In some configurations, the mask assembly can be configured to be fully positioned lower than a bridge of a nose of a face of a user and to provide an exposed bridge of the nose of the user. The mask seal can comprise a nasal region comprising at least one nasal opening, a first paddle on a first side of the nasal region and a second paddle on a second side of the nasal region. The first paddle is configured to contact one side of the nose of the user and the second paddle is configured to contact the other side of the nose of the user.

Systems, methods, or devices relate to a head mounted display providing a landscape panel layout. In examples, the landscape panel layout includes at least one optical display having a source driver positioned opposite a nasal region, and at least one chamfer cut along a side of the optical display non-adjacent to the source driver. The at least one chamfer cut generates an increased interpupillary distance (IPD) with a second optical display.

A mask is configured to contact a face of a user along a contact surface of the mask, where the contact surface is formed from a plurality of components, and the mask includes: a nose component configured to contact a nasal region of the user along a first portion of the contact surface of the mask, the first portion of the contact surface has a customized configuration to fit a configuration of the nasal region of the user; and a main assembly configured to contact a cheek region and a mandible region of the user along a second portion of the contact surface of the mask. A corresponding method of manufacturing a mask is also disclosed.

The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a sino-nasal region of a patient for the treatment of headache disorders.

The utility model discloses a beauty face mask which comprises a face mask body, the face mask body is provided with a face skin side, and the face skin side is provided with a forehead area, a nose area, upper cheek areas located on the left side and the right side of the nose area, lower cheek areas located below the upper cheek areas and masseter areas located on the sides, away from the nose area, of the upper cheek areas. The forehead area, the nose area, the cheek area, the cheek area and the masseter area are used for respectively corresponding to each part of a human face; the physical therapy light source is installed on the mask body to emit light out of the face skin side, the physical therapy light source comprises a plurality of physical therapy lamps, and the multiple physical therapy lamps are distributed in the forehead area, the upper cheek area, the lower cheek area and the masseter area; the distribution density of the physiotherapy lamps in the upper cheek area is larger than the distribution density of the physiotherapy lamps in the lower cheek area and the masseter area. The upper cheek areas with high skin problems on the face of the human body can be irradiated by denser physical therapy light, so that the physical therapy effect on the upper cheek areas on the left side and the right side of the nose on the face of the user is improved, light irradiation on the lower cheek areas, masseter areas and other areas with low skin problems is reduced, and the effective utilization rate of the physical therapy light is improved.

Devices for therapeutic nasal neuromodulation and associated systems and methods are disclosed herein. A system for therapeutic neuromodulation in a nasal region configured in accordance with embodiments of the present technology can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.

The invention generally relates to systems and methods for targeting of specific tissue(s) of interest in a sino-nasal region of a patient for the treatment of a rhinosinusitis condition. A device of the present invention includes an end effector comprised of one or more segments, each segment comprising one or more struts which can be in the form of loop-shaped struts or independent struts and each comprising a flexible printed circuit board (PCB) member for delivering energy to one or more target sites within the sino-nasal cavity of the patient while minimizing or avoiding collateral damage to surrounding or adjacent non-targeted tissue, such as blood vessels, bone, and non-targeted neural tissue.

The invention provides systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition. The system includes a device including a multi-segment end effector for delivering energy to one or more target sites within the nasal cavity of the patient. The multi-segment end effector includes a first segment and a separate second segment, wherein each of the first and second segments is transformable between a retracted configuration and an expanded deployed configuration, the first segment having a first geometry when in the deployed configuration to complement anatomy at a first location within the nasal cavity and a second segment having a second geometry when in the deployed configuration to complement anatomy at a second location within the nasal cavity.

The invention generally relates to systems and methods for targeting of specific tissue(s) of interest within a sino-nasal region of a patient, specifically sinus regions (i.e., ostia and sinus cavities), for the treatment of chronic sinusitis conditions.

The utility model relates to a nose area heating mask which comprises a mask body, a pair of fixing bands and at least one heating piece, the fixing bands are connected to the two sides of the mask body respectively, and the heating piece is installed on the upper portion of the mask body and heats air around the nasal cavity of a user when the user wears the mask on the face. Air entering the nasal cavity is heated to a proper temperature, so that the integrity of a respiratory mucosal barrier and the activity of immune cells are favorably maintained, and the defense capability on viruses is enhanced.